BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
T cell differentiation
,
HIV infection
,
Prostate
,
Nosology
,
Vitamin E
,
rs3825942
,
EGFR
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
CYSLTR2
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Eosinophil of peripheral blood
Superior cervical ganglion
Basophil of peripheral blood
B lymphocyte (naive) of spleen
Appendix
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Meningitis
Viral infections of the central nervous system
Hemorrhagic shock
COVID-19
Pain
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Nedocromil
Levobunolol
Carisoprodol
Cefixime
Am 580
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Pdgfrb
ZNF503
STK32B
PIK3CG
MIR211
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Direct evidence that the GPCR CysLTR2 mutant causative of uveal melanoma is constitutively active wi…
Activating cysteinyl leukotriene receptor 2 (CYSLTR2) mutations in blue nevi.
Involvement of mutant and wild-type CYSLTR2 in the development and progression of uveal nevi and mel…
The CysLT2R receptor mediates leukotriene C4-driven acute and chronic itch.
CysLT2R Antagonist HAMI 3379 Ameliorates Post-Stroke Depression through NLRP3 Inflammasome/Pyroptosi…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Study of Immunotherapy Plus ADI-PEG 20 for the Treatment of Advanced Uveal Melanoma
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ